Approvals/TGA/SPEVIGO spesolimab (rch) 450 mg in 7.5 mL concentrated solution for infusion vial

Approved

STANDARD

SPEVIGO spesolimab (rch) 450 mg in 7.5 mL concentrated solution for infusion vial

Boehringer Ingelheim Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 1823f246d08c3b54
Product Name: SPEVIGO spesolimab (rch) 450 mg in 7.5 mL concentrated solution for infusion vial
Artg Id: 388597
Artg Name: SPEVIGO spesolimab (rch) 450 mg in 7.5 mL concentrated solution for infusion vial
Sponsor: Boehringer Ingelheim Pty Ltd
Company Detail Path: /organization/boehringer-ingelheim-pty-ltd
Artg Date: 2023-11-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/1e2e5ee0d7bcc7ad8b9b5bed991f20f9.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/94306339823ef230fda5cdc4ee029572.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

1823f246d08c3b54

Type

Standard